SYRS - Syros Pharmaceuticals EPS misses by $0.05 beats on revenue August, 01 2019 07:35 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (NASDAQ:SYRS): Q2 GAAP EPS of -$0.47 misses by $0.05.More news on: Syros Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...